Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank36
5Y CAGR-69.9%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-69.9%/yr
Long-term compound
Percentile
P36
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
20250.30%
202416.67%
202317.53%
2022-14.58%
20211.15%
2020122.96%
2019-28.32%
2018209.46%
2017-9.61%
201662.69%